Product Images Fenofibric Acid Delayed-release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Fenofibric Acid Delayed-release NDC 42385-945 by Laurus Labs Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - 5ba82783 703a 4607 ac8c 8c15886e6621 01
Image - 5ba82783 703a 4607 ac8c 8c15886e6621 02
Each delayed-release capsule contains choline fenofibrate, equivalent to fenofibric acid 45 mg. This medication is used to reduce cholesterol and triglycerides levels in the blood. It comes in a child-resistant package and should be stored between 20°C and 25°C, protected from moisture. It is only available with a prescription and the full prescribing information is found in the package insert. The medication is manufactured for Laurus Generics Inc. in New Jersey and manufactured by Graviti Pharmaceuticals Pvt. Ltd. in India.*
image - 5ba82783 703a 4607 ac8c 8c15886e6621 03
Each delayed-release capsule contains choline fenofibrate equivalent to fenofibric acid 135 mg. This 90 capsule package of Fenofibric Acid Delayed-Release Capsules is child-resistant and should be stored at 20° to 25°C (68° to 77°F), protected from moisture. The manufacturing information is provided and the full prescribing information is available in the package insert. This medication is only available by prescription.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.